Maintenance phase treatment with divalproex [valproate semisodium] for post traumatic stress disorder
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2018
At a glance
- Drugs Valproate semisodium (Primary) ; Valproic acid
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Apr 2017 Status changed from completed to discontinued as the funding had expired.
- 04 Oct 2006 New trial record.